chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Passed out/passing out; Vertigo; Uncontrollable muscle twitching all over body; Dizziness/lightheadedness; Clammy hands/feet; Diarrhea; Gas; Rapid heart rate; Tingling in both feet/Tingling in bilateral feet; Liquid in both ears; Tiredness/fatigue; Nausea; Chills; A spontaneous report was received from a consumer, concerning a 24- year-old female who received Moderna's COVID vaccine and passed out and developed vertigo, dizziness, lightheadedness, uncontrollable muscle twitching, chills, clammy hands/feet/cold sweat, tingling in bilateral feet/paresthesia, fatigue ,nausea, liquid in the ears/ear discharge, diarrhea and gas/flatulence.  The patient's past medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event was reported as multivitamins (ascorbic acid, colecalciferaol, cyanocobalamin, pyridine hydrochloride, retinol palmitate, tocopherols mixed).  On 04 March 2021 , prior to the onset of the event, the patient received first of two planned doses of mRNA-1273 (lot number:13A21A) intramuscularly for prophylaxis of COVID 19 infection.  On an unknown date after receiving the first dose of the vaccine the patient passed out which was considered as serious event (medically significant). The patient also experienced vertigo, dizziness, lightheadedness, uncontrollable muscle twitching, chills, clammy hands/feet ,tingling in bilateral feet, fatigue ,nausea, liquid in the ears, diarrhea, gas and tiredness. The patient reported that she passed out 30 seconds later after getting injection and it was not due to vasovagal reaction. As per patient, tingling started when she woke up early in the morning but in feet only.  Treatment medications include dimenhydrinate and paracetamol. The patient took water and electrolytes for hydration.  Action taken with mRNA-1273 in response to events was considered as unknown.  The outcome of the events passed out and developed vertigo, dizziness, lightheadedness, uncontrollable muscle twitching, chills, clammy hands/feet/cold sweat, tingling in bilateral feet/paresthesia, fatigue ,nausea, liquid in the ears/ear discharge, diarrhea and gas/flatulence was considered as unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
This spontaneous report was received from a nurse and refers to a pediatric patient of unknown age and gender. The patient's concomitant medications, pertinent medical history and drug reactions or allergies were not reported. On 23-NOV-2016, the patient was vaccinated with the first dose of VAQTA injection, lot # reported as M022526 with expiation date 26-MAY-2017 (exact dose and route of administration were not reported). Subsequently, on 24-APR-2017, the patient received a booster dose of VAQTA injection, lot # M047658 with expiration date 28-OCT-2017 (exact dose and route of administration were not reported). No adverse effects were reported. Additional information has been requested.
temp of 100, chills, redness behow injection area, swollen around injection area, hot to the touch, hard, very very painful, sweats, dizzy
leg became swollen from knee up-some redness & was placed on Augmentin & recv x-ray for cellulitis in ER;4 days later broke out in red macular rash;
Within 15 minutes of vaccination, patient became diaphoretic.  Shortly after, had syncopal episode and was taken to urgent care for EKG evaluation.  No abnormal findings, and patient was discharged in alert, stable condition.
Received 1st COVID vaccine on 01/28/2021. Started to have some fevers, body ache, cough, mild sob starting 02/01/21. Tested COVID positive on 02/03/2021. Was been measuring SpO2 at home and was in the high 80s at home by 02 so referred to ED on 2/4/2021.  Admitted 02/05/2021.  Started on dexmethasone and supplemental oxygen.
temperature keeps going up - 100.5° at the moment; FATIGUE; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (temperature keeps going up - 100.5° at the moment) and FATIGUE (FATIGUE) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PYREXIA (temperature keeps going up - 100.5° at the moment) and FATIGUE (FATIGUE). At the time of the report, PYREXIA (temperature keeps going up - 100.5° at the moment) and FATIGUE (FATIGUE) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment reported.
That evening had tachycardia symptoms and trichina symptoms (about 12 hours after vaccine). I had fatigue and headache the following morning. Severe myalgias - in the epigastric cisternal area and in the back of my shoulder blades. 36 hours later - low grade temperature. At 48 hours I felt normal. Eye - 10 days later (vaccine) - I noticed a visual deficit in the left eye along with a line and the following day - on the 17th, I saw my ophthalmologist - left branch retinal vein occlusion.  Since then I've had an Forestine Angiogram:  and a video of my retina - branch retina arterial occlusion - so they are having trouble telling the difference between the two. I still am being followed for my eye. They did a carotid ultrasound - my carotids are fine. I am due to get an echo cardiogram. I am taking baby aspirin mg for now - not sure if it's helping or not. It takes a year and a half to go away.
weakness; aches; Jitteriness; shortness of breath; screaming headache for 4 days; sick to his stomach and not eating; sick to his stomach and not eating; not feeling well; This is a spontaneous report from a contactable consumer or other non hcp. A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID VACCINE, solution for injection, Batch/Lot Number: not reported), via an unspecified route of administration on an unspecified date, 2.5 weeks ago, as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, last Thursday, the patient experienced weakness, aches, jitteriness, shortness of breath, screaming headache for 4 days, sick to his stomach and not eating and overall, not feeling well. The patient called to ask about getting second shot, to know if his side effects are normal and how long are, they supposed to last, because he was told they could dissipate in a few days, but he was almost at 21 days now. On an unspecified date, Wednesday, it will be his recommended 21 days for second dose, but the patient was stuck in the middle on whether or not to get the second shot. The patient stated that he saw online that they were supposed to dissipate, and he was almost at the 21-day mark. He was confused on why he was still having these side effects. The patient was just an average Joe that got the vaccine, and he was feeling fine before shot. Investigation assessment was not provided. The outcome of all the events was unknown.  Information about lot/batch number is requested.
11MAR91 mom called & stated that infant had swelling, redness & knot @ site of inject; MD called, advised warm compresses to site;
An attorney alleges that a female received Tetanus and Diphtheria Toxoids Absorbed, Purogenated and influenza virus vaccines on 13 DEC 2000. Immediately following immunization, the patient experienced excruciating ("beyond description") pain, severe burning and a throbbing/pulsating sensation, that was so "bad", she was unable to sleep the entire night. The pain in her arm radiated into her neck and shoulder. She notified her physician who indicated that "it" was normal and would subside. The patient continued experiencing right arm and hand pain with 2 fingers on her right hand "drawing". As time moved forward, she experienced weakness and twitching in both her arms. Between May and June 2002, the patient's condition began to deteriorate; she was unable to use either arm for anything. She also experienced difficulty breathing. In August 2001, she was hospitalized for respiratory failure and placed into intensive care unit. She was released in September 2001 and had lost the use of both her arms. Her neck muscles had deteriorated to the point that she need assistance to maintain head elevation. Her weakness and deterioration affected her lungs and throat. The patient could barely breathe and had difficulty swallowing. According to the attorney, her problems were so severe, she was intubated and a feeding tube was inserted. As of the date of this report, the patient required 24 hour care due to her "injuries". As of the date of this report, no further information was available.
This spontaneous report as received from a pharmacist refers to an unspecified number of patient of unknown age and gender. No information on patients' medical history or concurrent conditions was provided. On an unknown dates, the patients were vaccinated with the doses of improperly stored PNEUMOVAX 23 injection, lot # K018833 with expiration date 20-APR-2016, lot# K021881 with expiration date 30-JUL-2016 and lot# K007262 with expiration date 25-NOV-2016 (dose and route of administration were not reported). No information on patients' concomitant medications was provided. No adverse effects were reported. This is one of the several reports from the same reporter. Additional information has been requested.
Chills, body aches, nausea, headache, sore throat, swollen lymph nodes in neck and armpits, lasting for about 12 hours. Sore armpits continue through 05/12/2010.
patient developed nodules on the lips; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single. for covid-19 immunisation. Relevant medical history included: "injected in the lips with a non-Allergan dermal filler" (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: LIP DISORDER (non-serious), outcome "not recovered", described as "patient developed nodules on the lips".  Additional information: Patient (who is also a health professional) reported being injected in the lips with a non-Allergan dermal filler. The patient received this COVID-19 vaccine two weeks later. A week later, the patient developed nodules on the lips. This was a Pfizer COVID-19 vaccine reaction. The event is ongoing.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Client at vaccination table. per NP client loss consciousness less than a second. history of episode of syncope. NP at station assessing client. client did not fall or hurt himself, NP was at clients side. EMT called VS obtained at 2:48pm HR 63 BP 86/47 o2sat 97%, VS at 2:50pm  HR 64 BP 91/57 o2sat 98%,  last VS obtained at 3:07pm  HR 77 BP 95/58 o2sat 98%. client remained in observation until 3:28pm no other complaints. client left observation with father at his side, client ambulating on his own.
Patient with CVA on 8/9/2021 and would like reported for monitoring.  "HPI per admitting physician with additions: "Pt is a 79-year-old female  With past medical history significant for  CVA, HTN, GERD,  presents to be evaluated for arm weakness. Pt states that yesterday evening she began experiencing right arm weakness and was unable to hold utensils or a pen. Pt denies other weakness, numbness, tingling, fever, chills, cp, sob, emesis, diarrhea etc. SHe does not take blood thinners. She had expecting the symptoms to improve but they did not so she came to the emergency room for further evaluation and treatment. In the ER CT revealed an old MCA territory infarct and a left frontoparietal hypodensity suspicious for subacute infarction. Telemetry neurology was consulted and did not recommend any aspirin or Plavix. Patient was also bradycardic down to the 50s at times in the emergency room."   CVA Patient presented with right arm weakness, inability to hold utensils or pen on presentation CT showed subacute left frontoparietal infarct, old right temporal lobe infarct also seen.  Telemetry Neurochecks Fall precautions MRI of the brain showed acute watershed infarct at the left subcortical central sulcus, no hemorrhagic transformation. MRA of the head and neck showed no evidence of significant stenosis, dissection or aneurysm Echocardiogram showed LVEF of 65 to 70%, no evidence of shunting, mild tricuspid regurgitation. Neurology was consulted: Recommended aspirin 81 mg and Plavix for at least 3 months, discontinued Crestor and start atorvastatin 81 mg for 6 months.  Neurology also recommended event monitor and cardiology follow-up as outpatient.  Cardiology was consulted and plan to send event monitor to patient's home. Patient was recommended to follow-up with neurology in 2 to 3 weeks. 8/11 patient was evaluated by PT/OT and speech, and found not to have further skilled needs at this time.  Patient's hand grip and arm weakness have improved.  She was discharged with follow-up plan as above.  Recommended medications were sent to her pharmacy"
felt ill; Headaches and body aches; sore throat; runny and stuffy nose; runny and stuffy nose; weakness; fatigue and feels tired when talks; Headaches and body aches; This spontaneous case was reported by a patient and describes the occurrence of MALAISE (felt ill), PAIN (Headaches and body aches), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny and stuffy nose) and NASAL CONGESTION (runny and stuffy nose) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced MALAISE (felt ill), PAIN (Headaches and body aches), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny and stuffy nose), NASAL CONGESTION (runny and stuffy nose), ASTHENIA (weakness), FATIGUE (fatigue and feels tired when talks) and HEADACHE (Headaches and body aches). At the time of the report, MALAISE (felt ill), PAIN (Headaches and body aches), OROPHARYNGEAL PAIN (sore throat), RHINORRHOEA (runny and stuffy nose), NASAL CONGESTION (runny and stuffy nose), ASTHENIA (weakness), FATIGUE (fatigue and feels tired when talks) and HEADACHE (Headaches and body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants were reported. No treatment was reported.
w/in 10min pt had approx 2-3cm erythema & 1cm wheal-no resp distress tx w/DPH observation-recheck next day parents reported few wheals on back which resolved-no wheals/erythema p/24hr;
13 year old son received the Moderna COVID-19 Vaccine instead of the Pfizer vaccine; slight fever; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (13 year old son received the Moderna COVID-19 Vaccine instead of the Pfizer vaccine) and PYREXIA (slight fever) in a 13-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (13 year old son received the Moderna COVID-19 Vaccine instead of the Pfizer vaccine) and PYREXIA (slight fever). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Fever, at a dose of 1 UNK. At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (13 year old son received the Moderna COVID-19 Vaccine instead of the Pfizer vaccine) had resolved and PYREXIA (slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were taken by the patient.
Headaches so bad that I feel like I'm going to throw up.  Happens every day.  Sometimes twice a day.
bacterial infection; minor sinus surgery; chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BACTERIAL INFECTION (bacterial infection), SURGERY (minor sinus surgery) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Sinus operation (Patient had a minor sinus surgery 3 weeks ago and picked up a bacterial infection after on an unspecified date. had chills,  ear-nose-throat (ENT) doctor prescribed him with amoxicillin to take for 5 days).    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BACTERIAL INFECTION (bacterial infection), SURGERY (minor sinus surgery) and CHILLS (chills). The patient was treated with AMOXICILLIN for Bacterial infection, at a dose of UNK dosage form. At the time of the report, BACTERIAL INFECTION (bacterial infection), SURGERY (minor sinus surgery) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medication include amoxicillin.  Action taken with mRNA-1273 in response to the event was unknown   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Additional information received captured reporter contact details.
Developed hemophagocytosis syndrome (hemophagocytic lymphohistiocytosis) resulting in hospitalization
Patient reported to her doctor's office today with symptoms consistent with Bell's Palsy.  She stated that the facial symptoms started mid morning today on 4/5/21.  Last week ( week of 3/28 to 4/3) she reports that she felt "weird".  She felt as if there were cool water running under her skin at all times.  She also states that when anything touches her skin, it feels very cold.  For example, when running her hands under warm water, it feels like ice water on her hands.  When setting her bare arms on her desk, it feels as if they are being set on ice and when her pants rub against her legs it feels as if they are wet and cold.  She also stated that the top 1/3 of her back was tingly and felt as if she had applied Biofreeze to it, but she had put nothing on her back.  Her tip of her tongue feels as if it is "burnt" and she can not tasted anything on the front part of her tongue.  She needs to get things way in the back of her mouth before she can taste them. On 4/3/21 she states that her lips began tingling as if they were having numbing medication wearing off from a dental visit, but she had done nothing different.  On 3/31 her lower back also felt as if it had a pinched nerve.  Today on 4/5/21 she has the Bell's Palsy on her face that started mid morning and she complains of her nose feeling tingly also.  She also feels as if she is retaining fluid.
4.2 by 6.4cm cellulitis and redness to Rt upper arm after a few hours of getting the vaccine. Pt was given a script for DURICEF caps 500mg 1 cap PO BID x 10 days.
Patient received the second Moderna vaccine too early. First Moderna vaccine was given on 06/22/2021. Vaccine was given 11 days too early. Patient did not have any adverse reactions.
pt recvd vax;c/o painful glands in neck, numbness in arms to fingers,began 17nov94;seen in hlth svc;23nov94 pain in knee;seen in er; inc sed rate - 47;30nov94 improving occasional numbness of arms at noc;
(L) arm red, swollen, knotted area @ injection site - warm to touch.
Information has been received from a registered nurse concerning a 20 year old female with acute lymphocytic leukaemia treated with chemotherapy (1989) and a drug allergy to BENADRYL (hives, trouble breathing) who on 22-FEB-2007 at 10:00, was vaccinated IM into the left arm with a first dose of Gardasil (Lot# 654741/0013U). Concomitant therapy included DEPO-PROVERA. "Within a day or two later," the patient's left forearm swelled from the injection site to the upper arm after lifting weights of 20 to 40 pounds. It was reported that the patient denied any erythema or itching. Unspecified medical attention was sought. No laboratory diagnostic studies were performed. After 2 to 3 days, the swelling resolved. It was also reported the patient has not yet received the second dose of the vaccine. No product quality complaint was involved. Additional information has been requested.  01/07/2008 This is in follow-up to report(s) previously submitted on 7/16/2007; 10/8/2007. The day following immunization, the patient's left upper arm and forearm swelled. The patient described that her forearm "swelled to the size of her upper arm". She noticed this after lifting weights (20-40 pounds). It was reported that the patient denied any itching, erythema, SOB, wheeezes or pain. Unspecified medical attention was sought. No laboratory diagnostic studies were performed. On 26-FEB-2007, the patient recovered. No product quality complaint was involved. Additional information is not expected.
Sore throat; left side body soreness and tender like; left side body soreness and tender like; Left side headache; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), TENDERNESS (left side body soreness and tender like), PAIN (left side body soreness and tender like) and HEADACHE (Left side headache) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), TENDERNESS (left side body soreness and tender like), PAIN (left side body soreness and tender like) and HEADACHE (Left side headache). At the time of the report, OROPHARYNGEAL PAIN (Sore throat), TENDERNESS (left side body soreness and tender like), PAIN (left side body soreness and tender like) and HEADACHE (Left side headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medication was reported.  Patient gave consent for safety to Follow-up.
My wife still has morning nausea from the second shot.; This is a spontaneous report from a contactable consumer or other non-HCP who reported for his wife.  A female patient of an unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date, the patient experienced nausea. Clinical course was reported as my wife still has morning nausea from the second shot. The clinical outcome of the event was not recovered.  Lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected